Director - Rare Disease Commercial Execution job in Plainsboro
Sign in
Create a candidate account
New Jersey (NJ),
Plainsboro
Job Code: | 302353-en_US |
Employer: | Novo Nordisk Inc. |
Category: | Business Development |
Job Type: | Full Time |
Location | |
Country: | United States |
State: | New Jersey (NJ) |
City: | Plainsboro |
Post Date: | 03/16/2024 |
Description | |
About the Department The Strategy & Rare Disease (STARS) organization drives the long-term strategic direction of Novo Nordisk Inc. (NNI)/North America Operations (NAO) and leads all US commercial efforts for Novo Nordisk's Rare Disease portfolio. The mandate of STARS is to facilitate the development and to coordinate the execution of the long-term strategy, defining a sustainable business model in US beyond a 5-year time horizon. This department serves as the insiders of the US market when informing and help shaping upstream decisions around future investments and assets. The Rare Disease portfolio includes products in the hemophilia and growth disorders therapeutic areas, new products in the pipeline, and products acquired through business development efforts in existing and new areas. The STARS team collaborates and partners with groups across NAO, Research & Early Development, Development, innovation hubs across NN, other affiliates, and global. We're looking for individuals who are enterprise thinkers, inclusive leaders, and strong collaborators, as we embark on shaping our future. **THIS IS A HOME OFFICE ROLE AND IS BASED IN PLAINSBORO, NEW JERSEY** The Position The Director, Rare Disease Commercial Execution is responsible for managing and driving the execution of therapy area and brand strategies, as well as organizational priorities and commercial initiatives across the Rare Disease portfolio. A key leader within the Rare Disease business unit and the Commercial Excellence team driving strategic planning, commercial operations, and extraordinary execution. Provides executive communications, meeting planning, and generalist support to enable the Commercial Excellence team and the Rare Disease LT. Responsible for overall sales and marketing effectiveness and contributes to building best-in-class commercial capabilities. Relationships The position reports to the Sr. Director, Rare Disease Commercial Excellence and serves as a critical partner to the extended Rare Disease Leadership Team. This individual will work cross-functionally across home office and field teams on business planning, analytics, translating marketing strategy into field action, ensuring excellence in execution, and the tracking and reporting of progress towards goals. They will influence at all levels and ultimately have a significant impact on the future of the Rare Disease portfolio, helping to serve patients and providers across the Rare Disease community. Essential Functions
Physical Requirements 0-10% overnight travel required. Qualifications
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we're life changing. Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations. If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications. |
ref: (302353-en_US) 47 days ago
|